Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.33 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | CPA1 | P15085 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16859599 | 0.81 | — | — | |
| SCHEMBL7073739 | 0.80 | PPARA (0.42) | GRIK1GRIK2CYP2C19CPA1 | |
| SCHEMBL273058 | 0.74 | TDP1 (0.42) | GRIK1GRIK2CYP2C19CPA1TSHR | |
| SCHEMBL28237464 | 0.72 | TSHR (0.41) | TSHR | |
| SCHEMBL28010130 | 0.72 | GRIK1 (0.37) | GRIK1GRIK2CYP2C19CPA1TSHR | |
| SCHEMBL28575140 | 0.72 | GRIK1 (0.37) | MAPTGRIK1GRIK2CYP2C19CPA1 | |
| SCHEMBL5718445 | 0.71 | MAPT (0.42) | MAPTFFAR1 | |
| SCHEMBL19974352 | 0.71 | MAPT (0.42) | MAPTFFAR1 | |
| SCHEMBL14780782 | 0.71 | — | — | |
| SCHEMBL11034749 | 0.71 | GRIK1 (0.42) | MAPTGRIK1GRIK2CYP2C19CPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10918579-B2 | Density balanced high impact perfume microcapsules | FIRMENICH SA (CH) | 2021-02-16 | — | — | US | claimed |
| US-20150182656-A1 | Perfume Compositions | GIVAUDAN S.A. (CH) | 2015-07-02 | — | — | US | claimed |
| US-20150079017-A1 | Perfume Compositions | GIVAUDAN S.A. (CH) | 2015-03-19 | — | — | US | claimed |
| US-20140235520-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2014-08-21 | — | — | US | claimed |
| US-20130230479-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2013-09-05 | — | — | US | claimed |
| US-20130039876-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2013-02-14 | — | — | US | claimed |
| US-20130039877-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2013-02-14 | — | — | US | claimed |
| EP-2049638-B1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2012-10-03 | — | — | EP | claimed |
| EP-2049637-B1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2012-05-30 | — | — | EP | claimed |
| EP-1869150-B1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES BV (NL) | 2012-05-30 | — | — | EP | claimed |
| US-20110182832-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL SERVICES B.V. (NL) | 2011-07-28 | — | — | US | claimed |
| US-20090263344-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2009-10-22 | — | — | US | claimed |
| US-20090257974-A1 | Perfume Compositions | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2009-10-15 | — | — | US | claimed |
| WO-2009052643-A1 | ANTI-MALODOUR COMPOSITIONS | GIVAUDAN SA (CH) | 2009-04-30 | — | — | WO | claimed |
| EP-2049637-A1 | PERFUME COMPOSITIONS | Givaudan Nederland Services B.V. (NL) | 2009-04-22 | — | — | EP | claimed |
| EP-2049638-A1 | PERFUME COMPOSITIONS | Givaudan Nederland Services B.V. (NL) | 2009-04-22 | — | — | EP | claimed |
| WO-2008023142-A1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-02-28 | — | — | WO | claimed |
| WO-2008017820-A1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-02-14 | — | — | WO | claimed |
| US-20260085253-A1 | LILY OF THE VALLEY ODORANT | FIRMENICH & CIE (CH) | 2026-03-26 | — | — | US | disclosed |
| WO-2008017820-A1 | PERFUME COMPOSITIONS | GIVAUDAN NEDERLAND SERVICES B.V. (NL) | 2008-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085253-A1 | LILY OF THE VALLEY ODORANT | PIR, ALG3, ENY2 | MAPT 1117/4885GRIK1 2321/4885GRIK2 1704/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.